Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-13 | 2019-07-12 | 78484 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-08-21 | 2019-10-15 | 92022 |
APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2019-10-09 | 2019-11-04 | 95871 |
APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108927 |
APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2020-10-07 | 2021-01-26 | 125806 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2020-11-19 | 2020-11-27 | 128594 |
APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131148 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-02-26 | 2021-08-23 | 134811 |
APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-18 | 2021-07-26 | 141247 |
APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2023-01-13 | 166604 |
APO-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2017-03-17 | 2017-07-17 | 3160 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-01-31 | 2018-05-05 | 37732 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-25 | 2018-11-22 | 65599 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-03 | 2019-05-17 | 71136 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77852 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-24 | 2020-08-17 | 118766 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-07 | 2021-09-20 | 138960 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-11-09 | 2022-01-06 | 148999 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-28 | 2022-03-24 | 153783 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-12-17 | 159703 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |